Clinical trials: Inflammatory Bowel Disease 1
Perianal Fistula Due to Crohn's Disease
Expanded Access Protocol for STOMP-II Patients Who Were Unable to Receive Treatment Subsequent to Adipose Tissue Collection
The goal of this Expanded Access Protocol is to provide expanded access of AVB-114 to patients who had their fat tissue collected as part of a clinical trial (STOMP-II), but who were subsequently not treated with AVB-114 because…
- Trial name
- EAP-STOMP2 (NCT06509828)
- Testing
- AVB-114
- Sponsor
- Avobis Bio, LLC
Ulcerative Colitis, Crohn's Disease
Study on Cannabinoid Receptor Expression in Gastrointestinal Diseases
The purpose of the study is to investigate phospholipid ligands and their receptors in inflammatory bowel diseases and colon cancer.
- Conditions
- Ulcerative Colitis, Crohn's Disease, Colon Cancer
- Trial name
- NCT02735941
- Where
- Austria
- Volunteers
- 31 people, healthy volunteers welcome
- Sponsor
- Medical University of Graz
Crohn Disease
A Study of a FimH Blocker, EB8018, in Crohn's Disease Patients
Enterome small molecule drug EB8018 is a first-in-class FimH blocker to be studied in Crohn's disease patients. The proposed indication for EB8018, as an add-on therapy, will be the treatment of adult patients suffering from…
- Trial name
- EBFIM117 (NCT03709628)
- Testing
- EB8018 (First-in-class FimH blocker)
- Where
- 5 sites in Austria, France and 2 more
- Volunteers
- 8 people
- Sponsor
- Enterome
Crohn's Disease
A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease.
Crohn's disease (CD) is a long-lasting disease that causes severe inflammation (redness, swelling), in the digestive tract, most often affecting the bowels.
- Trial name
- AFFIRM (NCT06063967)
- Testing
- Risankizumab SC
- Where
- 179 sites in United States, Argentina and 18 more
- Volunteers
- 289 people
- Sponsor
- AbbVie
Inflammatory Bowel Diseases
Inflammatory Bowel Disease Cohort in Nantes
The CELESTE cohort will be a three-center prospective cohort associated with the creation of a biobank including Inflammatory Bowel Diseases (IBD) patients with active disease
- Trial name
- CELESTE (NCT06256393)
- Testing
- Collection of biological samples
- Where
- 3 sites in France
- Volunteers
- 360 people
- Sponsor
- Nantes University Hospital
Crohn Disease (CD)
Prospective Risk Evaluation and Detection of Crohn's Disease in First-degree Relatives
The PREDICT-CD study aims to validate a risk score for the development of Crohn's disease, based on serological biomarkers and lifestyle-related factors.
- Trial name
- PREDICT-CD (NCT07316621)
- Where
- 10 sites in Italy, Netherlands and 4 more
- Volunteers
- 10,000 people, healthy volunteers welcome
- Sponsor
- GLSMED Learning Health S.A.
Crohn's Disease (CD)
The Impact of Time Restricted Feeding in Crohn's Disease
Time-restricted feeding (TRF) is a dietary regimen involving the consumption of food and liquids within a defined time window with or without additional restriction on dietary composition.
- Trial name
- TRF-CD (NCT04271748)
- Testing
- Time Restricted Feeding
- Where
- United States
- Volunteers
- 15 people
- Sponsor
- Weill Medical College of Cornell University
Pediatric, Colon Capsule Endoscopy
SECOND GENERATION COLON CAPSULE ENDOSCOPY (CCE-2) IN PEDIATRIC CROHN'S DISEASE (CD).
This prospective pilot study of 40 pediatric patients with Crohn's Disease, that are candidates for endoscopic and imaging re-evaluation, examines the Given Diagnostic System and the second generation of colon capsule in…
- Trial name
- NCT02199626
- Testing
- Second generation of colon capsule endoscopy (GIVEN IMAGING)
- Where
- Italy
- Volunteers
- 40 people
- Sponsor
- Azienda Policlinico Umberto I
Crohn's Disease, Intestinal Tuberculosis
Development of a Prediction Model for Differential Diagnosis Between Intestinal Tuberculosis and Crohn's Disease
The aim of this study is to develop a scoring system and a prediction model for differential diagnosis between intestinal tuberculosis and Crohn's disease.
- Trial name
- NCT01392365
- Where
- South Korea
- Volunteers
- 117 people
- Sponsor
- Asan Medical Center
Crohn's Disease
Infliximab for the Prevention of Recurrent Crohn's Disease After Surgery
A randomized, placebo-controlled pilot study to determine endoscopic recurrence of Crohn's disease 12 months after curative, resective ileal or ileocolonic surgery in patients receiving post-operative infliximab or placebo
- Trial name
- NCT00688636
- Testing
- infliximab
- Where
- United States
- Volunteers
- 24 people
- Sponsor
- University of Pittsburgh
Inflammatory Bowel Diseases, Ulcerative Colitis
Non-Invasive Monitoring Through Bowel Ultrasound in Paediatric Inflammatory Bowel Disease Study
Rates of inflammatory bowel disease (IBD) are increasing rapidly in children and young people, and targets for management are becoming more demanding, with better control of disease to prevent complications, cancers and…
- Conditions
- Inflammatory Bowel Diseases, Ulcerative Colitis, Crohn Disease, Pediatric Crohns Disease
- Trial name
- NIMBUS (NCT05673278)
- Testing
- Bowel Ultrasound Scan
- Where
- United Kingdom
- Volunteers
- 50 people
- Sponsor
- Cardiff and Vale University Health Board
Inflammatory Bowel Disease
A Randomized Crossover Trial of Bright Light Therapy in Crohn's Disease on Intestinal Barrier Homeostasis
Crohn's Disease (CD) and Ulcerative Colitis (UC), collectively known as inflammatory bowel disease (IBD), are two of the most significant chronic conditions of the gastrointestinal tract (GIT) and affects over 1.5 million…
- Trial name
- NCT05579392
- Testing
- Bright Light Therapy
- Where
- 2 sites in United States
- Volunteers
- 30 people
- Sponsor
- Rush University Medical Center
Perianal Fistula, Crohn Disease
Autologous Adipose-derived Stem Cells (ASCs) for the Treatment of Perianal Fistula in Crohn Disease: A Pilot Study
Crohn's disease is an immunologically mediated inflammatory bowel disease with a reported incidence of 4.0-7.0, 7.1, and 1.34 per 100,000 persons in Europe, the U.S., and Korea, respectively.
- Trial name
- ASPEFIC1 (NCT02403232)
- Testing
- ASCs injection, Closure of fistula tract.
- Where
- Italy
- Volunteers
- 10 people
- Sponsor
- Papa Giovanni XXIII Hospital
Crohn Disease, Colitis, Ulcerative
Real-world Effectiveness of Ustekinumab in Participants Suffering From Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) With Extra-intestinal Manifestations or Immune-mediated Inflammatory Diseases
The purpose of this study is to assess the effectiveness of ustekinumab on extra-intestinal manifestations (EIMs) and immune-mediated inflammatory diseases (IMIDs) associated with inflammatory bowel disease (IBD) (both Crohn's…
- Trial name
- TENOR (NCT03606499)
- Testing
- Ustekinumab
- Where
- France
- Volunteers
- 111 people
- Sponsor
- Janssen Cilag S.A.S.
Ulcerative Colitis
Absolute Bioavailability, Safety, and Tolerability of Subcutaneous GS-5745 in Healthy Adults
This study will estimate the absolute bioavailability of subcutaneously injected GS-5745, characterize the safety, tolerability, and pharmacokinetics (PK) of GS-5745 after subcutaneous (SC) injection and intravenous (IV)…
- Trial name
- NCT02209987
- Testing
- GS-5745 SC, GS-5745 IV
- Where
- New Zealand
- Volunteers
- 28 people, healthy volunteers welcome
- Sponsor
- Gilead Sciences
Inflammatory Bowel Diseases, Crohn Disease
A Study to Characterize Multidimensional Model to Predict the Course of Crohn's Disease (CD)
The descriptive purpose of this study is to characterize clinical and nonclinical factors of participants with CD, participant flow and visits to other specialists in the hospitals of the healthcare network of the Autonomous…
- Trial name
- PREMONITION-CD (NCT03668249)
- Where
- 8 sites in Spain
- Volunteers
- 5,938 people
- Sponsor
- Takeda
Inflammatory Bowel Diseases, Crohn Disease
Effects of an Intermittent Reduced Calorie Diet on Crohn's Disease
The purpose of this study is to see how an Intermittent Calorie Reduced Diet (IRCD) that mimics fasting (also known as a fasting mimicking diet, FMD) effects inflammation in patients with mild to moderate Crohn's disease (CD).
- Conditions
- Inflammatory Bowel Diseases, Crohn Disease, Diet Modification
- Trial name
- NCT04147585
- Testing
- Intermittent Reduced Calorie Diet (IRCD)
- Where
- United States
- Volunteers
- 86 people
- Sponsor
- Stanford University
Inflammatory Bowel Diseases, Ulcerative Colitis
Development and Validation of a Self-reported Objective Index of Work Disability in Inflammatory Bowel Disease
Background theme Crohn's disease (CD) and ulcerative colitis (UC) are chronic diseases that alternate flares of active inflammation with periods of clinical remission.
- Conditions
- Inflammatory Bowel Diseases, Ulcerative Colitis, Crohn Disease, Disabling Disease
- Trial name
- IBD-OWDI (NCT03872726)
- Where
- Spain
- Volunteers
- 800 people, healthy volunteers welcome
- Sponsor
- Corporacion Parc Tauli
Crohn's Disease
Study About the Effect of Doxycycline and Acetylcystein in the Treatment of CD-associated Fistulae
The investigators will study whether local instillation of Doxycycline and Acetylcystein results in fistula closure in CD patients.
- Trial name
- NCT01012726
- Testing
- Colonoscopy
- Where
- Switzerland
- Volunteers
- 20 people
- Sponsor
- Gerhard Rogler
Crohn Disease
Comparing Hand-sewn (END-TO-END or Kono-S) to Stapled Anastomosis in Ileocolic Resection for Crohn's Disease
The aim of this multicenter randomised controlled trial is to compare the handsewn (end-to-end and Kono-S) to the stapled side-to-side ileocolic anastomosis after ileocolic resection for Crohn's disease with respect to 6 months…
- Trial name
- END2END (NCT05578235)
- Testing
- stapled side-to-side anastomosis, Handsewn anastomosis
- Where
- Netherlands
- Volunteers
- 165 people
- Sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.